Health Care · Nasdaq Copenhagen · FYE 12-31 · Prices AT CLOSE 2026-08-18 (DKK) Last DKK 43.90 · Day +1.76% · P/E (FY) 13.4× · 1Y +17.3% · Off 52W high −8.1% · Vol (1Y) 27.7% Price2023-08-18 → 2026-08-18 HLUN-B.CO close: DKK 35.0 on 2023-08-18 to DKK 43.9 on 2026-08-18. Split-adj closes · 240 of 1,001 · price returnⓘ At a glance No fair-value, short-interest or ownership figures on file for HLUN-B.CO. Key fundamentalsFY 2026 | P/E (FY)13.4× | | ROE12.8% | | Net margin13.0% | | ROIC10.8% | | Debt / equity0.45× | | Total debt / EBITDA1.57× | | EPS growth 3Y18.6% | | Sales growth 3Y10.5% |
FY ratios · TTM sales/earnings (DKK)ⓘ Trailing returns | YTD+4.9% | | 1Y+17.3% | | 3Y+35.3% | | Since incept. (ann.)+9.9% |
Total return · from 2022-06-10ⓘ Risk | Ann. volatility (1Y)27.7% | | Ann. volatility (3Y)29.1% | | Sharpe (1Y)0.73 | | Sharpe (3Y)0.47 | | Max drawdown (1Y)−21.9% | | Max drawdown (3Y)−42.9% | | Beta (3Y vs SPY)0.46 |
Daily returns, ann.ⓘ Top institutional holders13F 2026-Q1 No 13F holders on file for HLUN-B.CO. Latest reported quarters No reported quarters on file for HLUN-B.CO. Basis & disclosures - EOD closes · nothing imputed or averaged · absent “—”
- As-of differs by block · 13F = US long, 45+d lag, LOWER bound
- Not investment advice · no recommendation, price target or solicitation
- EDGAR + foreign registers · marketstack (licensed EOD) · spzco.com/methodology
| 
